Blood Adv in press

Combined BCL2 and BTK Inhibition in CLL Demonstrates Efficacy after Monotherapy with Both Classes.

Hyak JM, Huang Y, Rogers KA, Bhat SA, Grever MR, Byrd JC, Kittai AS, Jones D, Miller CR, Woyach JA